" /> Peroxisome biogenesis disorder 11a (zellweger) - CISMeF





Preferred Label : Peroxisome biogenesis disorder 11a (zellweger);

Symbol : PBD11A;

CISMeF acronym : CGH; CG13; PBD11A;

Type : Phenotype, molecular basis known;

Included titles and symbols : Peroxisome biogenesis disorder, complementation group 13; Peroxisome biogenesis disorder, complementation group h; CG13; CGH;

Description : Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006). For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100. Individuals with PBDs of complementation group 13 (CG13, equivalent to CGH) have mutations in the PEX13 gene. For information on the history of PBD complementation groups, see 214100.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the peroxisome biogenesis factor 13 gene (PEX13, 601789.0001);

Laboratory abnormalities : Elevated hexacosanoic acid; Elevated ratios of tetracosanoic and hexacosanoic acid to docosanoic acid in plasma; Elevated liver enzymes; 'Ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy;

Prefixed ID : #614883;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.